PTCY keeps on giving!

Vedran Radojcic, Leo Luznik

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


In this issue of Blood, Battipaglia and colleagues report improved outcomes for patients receiving posttransplant cyclophosphamide (PTCY) vs antithymocyte globulin (ATG) as backbone of their immunosuppression regimen after 1-antigen mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (alloHCT) for treatment of acute myeloid leukemia (AML).1

Original languageEnglish (US)
Pages (from-to)848-849
Number of pages2
Issue number11
StatePublished - Sep 12 2019

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'PTCY keeps on giving!'. Together they form a unique fingerprint.

Cite this